Musculoskeletal Infections: PET-CT and SPECT-CT Imaging Katrin D. M. Stumpe Klaus Strobel Juerg Hodler Infections of bones and joints are severe diseases that can result in debilitating joint destruction, joint…
Soft Tissue Inflammation: PET-CT and SPECT-CT Imaging Klaus Strobel Katrin D. M. Stumpe Gustav K. von Schulthess Soft-tissue infections, eluding clinical detection, occur in many settings. Because their therapy depends…
Physiologic Basis of Inflammation Imaging Achim H. Kaim Gustav K. von Schulthess Imaging of septic and sterile inflammation is frequently used in the management of these diseases, be it to…
PET and PET-CT in Radiation Treatment Planning Steven M. Larson Kenneth Rosenzweig Heiko Schöder John Humm Normal tissue tolerance in the region of irradiated tumor has been the major limitation…
Introduction Despite the successes of medical therapy, infectious disease and noninfectious inflammation remain major clinical problems in daily practice. Acute and chronic inflammation in general are characterized by different physiologic…
PET and PET-CT in Multiple Myeloma Sven N. Reske Anja Dankerl Multiple myeloma (MM) represents a malignant clonal proliferation of plasma cells and commonly results in an overproduction of monoclonal…
PET and SPECT-CT in Lymphoma Karoline Spaepen Sigrid Stroobants Positron emission tomography (PET) using fluorodeoxyglucose (FDG) is now widely used for staging and monitoring treatment results in patients with Hodgkin…
PET-CT and SPECT-CT of Malignant Melanoma Hans C. Steinert In our institution, whole-body integrated positron emission tomography (PET) and computed tomography (CT) with fluorodeoxyglucose (FDG) is restricted to patients with…
PET and PET-CT in Soft Tissue Sarcomas Janet F. Eary Soft tissue sarcomas are a complex group of neoplasms that are derived from mesenchymal tissue elements. They most commonly occur…
PET-CT and SPECT-CT of Bone Metastases Klaus Strobel Daniela B. Husarik Thomas F. Hany The skeletal system is the third most common localization of distant metastases of malignant tumors, following…
